Müller, B

Jerusalem, G; Farah, S; Courtois, A; Chirgwin, J; Aebi, S; Karlsson, P; Neven, P; Hitre, E; Graas, M P; Simoncini, E; Abdi, E; Kamby, C; Thompson, A; Loibl, S; Gavilá, J; Kuroi, K; Marth, C; Müller, B; O'Reilly, S; Gombos, A; ... (2021). Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy. Annals of oncology, 32(10), pp. 1256-1266. Elsevier 10.1016/j.annonc.2021.07.017

Müller, B; Evangelopoulos, D S; Bias, K; Wildisen, A; Zimmermann, H; Exadaktylos, A K (2011). Can S-100B serum protein help to save cranial CT resources in a peripheral trauma centre? A study and consensus paper. Emergency medicine journal, 28(11), pp. 938-40. London: BMJ Publishing Group 10.1136/emj.2010.095372

Müller, B; Baciu, D; Saner, H (2010). Kardiovaskuläres Risikomanagement bei schweren psychischen Störungen. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 10, pp. 679-682. Basel: EMH Editores Medicorum Helveticorum

Wille, T; Müller, B; Noth, D; Bürgi, U; Diem, P (2006). [Long-term follow up after antithyroid drug treatment in Graves' disease]. Praxis - schweizerische Rundschau für Medizin, 95(29-30), pp. 1121-7. Bern: Huber

Müller, B; Trepp, R (2004). [Diabetes update: preventing type 2 diabetes. Individualized stepwise therapy (oral antidiabetic agents). Multifactorial intervention]. Praxis - schweizerische Rundschau für Medizin, 93(18), pp. 753-62. Bern: Huber

Trepp, R; Müller, B; Ozdoba, Ch; Diem, P; Christ, ER (2003). [An unusual IV-expert opinion]. Praxis - schweizerische Rundschau für Medizin, 92(40), pp. 1689-92. Bern: Huber

Diem, P; Deplazes, M; Fajfr, R; Bearth, A; Müller, B; Christ, ER; Teuscher, A (2003). Effects of alcohol consumption on mortality in patients with Type 2 diabetes mellitus. Diabetologia, 46(11), pp. 1581-5. Heidelberg: Springer-Verlag 10.1007/s00125-003-1209-2

Müller, B; Trepp, R; Diem, P; Christ, E (2002). [The paradox of TSH elevation in Sheehan's syndrome]. Deutsche medizinische Wochenschrift, 127(49), pp. 2610-2. Stuttgart: Thieme 10.1055/s-2002-35929

Fajfr, R; Müller, B; Diem, P (2002). [Hypophyseal incidentaloma in a patient with autosomal dominant polycystic kidney disease]. Praxis - schweizerische Rundschau für Medizin, 91(25-26), pp. 1123-6. Bern: Huber

Pillai, R S; Will, C L; Lührmann, R; Schümperli, Daniel; Müller, B (2001). Purified U7 snRNPs lack the Sm proteins D1 and D2 but contain Lsm10, a new 14 kDa Sm D1-like protein. EMBO journal, 20(19), pp. 5470-5479. Nature Publishing Group 10.1093/emboj/20.19.5470

Noth, D; Gebauer, M; Müller, B; Bürgi, U; Diem, P (2001). Graves' ophthalmopathy: natural history and treatment outcomes. Swiss medical weekly, 131(41-42), pp. 603-9. Muttenz: EMH Schweizerischer Ärzteverlag

Müller, B; Merk, S; Bürgi, U; Diem, P (2001). [Calculating the basal metabolic rate and severe and morbid obesity]. Praxis - schweizerische Rundschau für Medizin, 90(45), pp. 1955-63. Bern: Huber

Michel, F; Schümperli, Daniel; Müller, B (2000). Specificities of Caenorhabditis elegans and human hairpin binding proteins for the first nucleotide in the histone mRNA hairpin loop. RNA - a publication of the RNA Society, 6(11), pp. 1539-1550. Cold Spring Harbor Laboratory Press

Martin, F; Michel, F; Zenklusen, D; Müller, B; Schümperli, Daniel (2000). Positive and negative mutant selection in the human histone hairpin-binding protein using the yeast three-hybrid system. Nucleic acids research, 28(7), pp. 1594-1603. Oxford University Press 10.1093/nar/28.7.1594

Müller, B; Bürgi, U (1999). [Acropachyderma in hyperthyroidism]. Schweizerische medizinische Wochenschrift, 129(42), p. 1560. Basel: B. Schwabe & Co.

Müller, B; de Marco, D; Bürgi, U; Mullis, PE (1999). [What is the value of determining immunoreactive GHRH in acromegaly?]. Schweizerische medizinische Wochenschrift, 129(33), pp. 1152-61. Basel: B. Schwabe & Co.

Walther, T N; Wittop Koning, T H; Schümperli, Daniel; Müller, B (1998). A 5'-3' exonuclease activity involved in forming the 3' products of histone pre-mRNA processing in vitro. RNA - a publication of the RNA Society, 4(9), pp. 1034-1046. Cold Spring Harbor Laboratory Press

Müller, B; Schümperli, Daniel (1997). The U7 snRNP and the hairpin binding protein: Key players in histone mRNA metabolism. Seminars in cell & developmental biology, 8(6), pp. 567-576. Elsevier 10.1006/scdb.1997.0182

Martin, F; Schaller, A; Eglite, S; Schümperli, Daniel; Müller, B (1997). The gene for histone RNA hairpin binding protein is located on human chromosome 4 and encodes a novel type of RNA binding protein. EMBO journal, 16(4), pp. 769-778. Nature Publishing Group 10.1093/emboj/16.4.769